| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | synaptic receptor adaptor activity | 3.38e-05 | 4 | 48 | 2 | GO:0030160 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 3.07e-04 | 11 | 48 | 2 | GO:0098919 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 4.34e-04 | 13 | 48 | 2 | GO:0098879 | |
| Domain | PH_dom-like | 4.21e-03 | 426 | 47 | 5 | IPR011993 | |
| Domain | PH | 5.18e-03 | 278 | 47 | 4 | SM00233 | |
| Domain | PH_DOMAIN | 5.25e-03 | 279 | 47 | 4 | PS50003 | |
| Domain | PH_domain | 5.32e-03 | 280 | 47 | 4 | IPR001849 | |
| Domain | PDZ | 5.36e-03 | 141 | 47 | 3 | PF00595 | |
| Domain | PDZ | 6.13e-03 | 148 | 47 | 3 | SM00228 | |
| Domain | - | 6.36e-03 | 150 | 47 | 3 | 2.30.42.10 | |
| Domain | PDZ | 6.48e-03 | 151 | 47 | 3 | PS50106 | |
| Domain | PDZ | 6.59e-03 | 152 | 47 | 3 | IPR001478 | |
| Domain | Quinoprotein_ADH-like_supfam | 7.87e-03 | 53 | 47 | 2 | IPR011047 | |
| Domain | DH_1 | 1.10e-02 | 63 | 47 | 2 | PS00741 | |
| Pubmed | 8.36e-09 | 101 | 51 | 6 | 10997877 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31803941 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10506216 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 28842166 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 33126897 | ||
| Pubmed | Expression profiles of the autism-related SHANK proteins in the human brain. | 2.11e-06 | 2 | 51 | 2 | 37953224 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 36100669 | ||
| Pubmed | Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. | 2.11e-06 | 2 | 51 | 2 | 22699619 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20800661 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31052177 | ||
| Pubmed | Selective Localization of Shanks to VGLUT1-Positive Excitatory Synapses in the Mouse Hippocampus. | 2.11e-06 | 2 | 51 | 2 | 27199660 | |
| Pubmed | SHANK3 in vagal sensory neurons regulates body temperature, systemic inflammation, and sepsis. | 2.11e-06 | 2 | 51 | 2 | 36845137 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 3.54e-06 | 440 | 51 | 7 | 34244565 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 26993600 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 10806096 | ||
| Pubmed | Cytokine-stimulated T lymphocyte proliferation is regulated by p27Kip1. | 6.32e-06 | 3 | 51 | 2 | 11086062 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 36098746 | ||
| Pubmed | Translational neurobiology in Shank mutant mice--model systems for neuropsychiatric disorders. | 6.32e-06 | 3 | 51 | 2 | 25917711 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 23583105 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 29970989 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 34741005 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 32564287 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 23897824 | ||
| Pubmed | Influence of cancer-related gene polymorphisms on clinicopathological features in colorectal cancer. | 1.26e-05 | 4 | 51 | 2 | 18205772 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 23468870 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 23184467 | ||
| Pubmed | Protrudin induces neurite formation by directional membrane trafficking. | 1.26e-05 | 4 | 51 | 2 | 17082457 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 12626503 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 16606358 | ||
| Pubmed | The insulin receptor substrate IRSp53 links postsynaptic shank1 to the small G-protein cdc42. | 2.10e-05 | 5 | 51 | 2 | 12504591 | |
| Pubmed | Distinct Requirements of CHD4 during B Cell Development and Antibody Response. | 2.10e-05 | 5 | 51 | 2 | 31042474 | |
| Pubmed | 2.56e-05 | 237 | 51 | 5 | 29564676 | ||
| Pubmed | Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity. | 4.41e-05 | 7 | 51 | 2 | 22802351 | |
| Pubmed | Direct interaction of GluRdelta2 with Shank scaffold proteins in cerebellar Purkinje cells. | 4.41e-05 | 7 | 51 | 2 | 15207857 | |
| Pubmed | CtIP-mediated resection is essential for viability and can operate independently of BRCA1. | 4.41e-05 | 7 | 51 | 2 | 24842372 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 10527873 | ||
| Pubmed | 4.68e-05 | 657 | 51 | 7 | 36180527 | ||
| Pubmed | The G protein-coupled receptor CL1 interacts directly with proteins of the Shank family. | 5.87e-05 | 8 | 51 | 2 | 10958799 | |
| Pubmed | Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switching. | 5.87e-05 | 8 | 51 | 2 | 23254285 | |
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 30319350 | ||
| Pubmed | Monoubiquitination of Syntaxin 5 Regulates Golgi Membrane Dynamics during the Cell Cycle. | 5.87e-05 | 8 | 51 | 2 | 27404360 | |
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 23657012 | ||
| Pubmed | PRMT5 is essential for B cell development and germinal center dynamics. | 9.42e-05 | 10 | 51 | 2 | 30604754 | |
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 21364747 | ||
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 12591596 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 18599325 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 26403076 | ||
| Pubmed | Advancing the understanding of autism disease mechanisms through genetics. | 1.63e-04 | 13 | 51 | 2 | 27050589 | |
| Pubmed | 1.63e-04 | 13 | 51 | 2 | 18796539 | ||
| Pubmed | 1.63e-04 | 13 | 51 | 2 | 14622142 | ||
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 21795692 | ||
| Pubmed | 2.05e-04 | 1116 | 51 | 8 | 31753913 | ||
| Pubmed | 2.19e-04 | 15 | 51 | 2 | 34835087 | ||
| Pubmed | 2.83e-04 | 17 | 51 | 2 | 27779093 | ||
| Pubmed | 2.83e-04 | 17 | 51 | 2 | 26627310 | ||
| Pubmed | 3.32e-04 | 638 | 51 | 6 | 33239621 | ||
| Pubmed | 3.63e-04 | 1215 | 51 | 8 | 15146197 | ||
| Pubmed | 3.65e-04 | 418 | 51 | 5 | 34709266 | ||
| Pubmed | 3.94e-04 | 20 | 51 | 2 | 21248711 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 4.07e-04 | 934 | 51 | 7 | 33916271 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 4.31e-04 | 670 | 51 | 6 | 22990118 | |
| Pubmed | Sin3a is essential for the genome integrity and viability of pluripotent cells. | 5.23e-04 | 23 | 51 | 2 | 22206758 | |
| Pubmed | 5.70e-04 | 24 | 51 | 2 | 11258795 | ||
| Pubmed | 8.35e-04 | 29 | 51 | 2 | 36800290 | ||
| Pubmed | The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity. | 8.35e-04 | 29 | 51 | 2 | 19208628 | |
| Pubmed | Interactomic analysis reveals a homeostatic role for the HIV restriction factor TRIM5α in mitophagy. | 8.92e-04 | 292 | 51 | 4 | 35545034 | |
| Pubmed | 8.93e-04 | 30 | 51 | 2 | 34974536 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 9.15e-04 | 774 | 51 | 6 | 15302935 | |
| Pubmed | 9.53e-04 | 131 | 51 | 3 | 28031328 | ||
| Pubmed | 1.06e-03 | 1431 | 51 | 8 | 37142655 | ||
| Pubmed | Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation. | 1.15e-03 | 34 | 51 | 2 | 30726710 | |
| Pubmed | 1.22e-03 | 35 | 51 | 2 | 32504627 | ||
| Pubmed | 1.22e-03 | 547 | 51 | 5 | 37267103 | ||
| Pubmed | 1.24e-03 | 549 | 51 | 5 | 38280479 | ||
| Pubmed | 1.35e-03 | 148 | 51 | 3 | 35676246 | ||
| Pubmed | 1.36e-03 | 37 | 51 | 2 | 24335282 | ||
| Pubmed | 1.41e-03 | 1497 | 51 | 8 | 31527615 | ||
| Pubmed | 1.42e-03 | 331 | 51 | 4 | 29199018 | ||
| Pubmed | 1.43e-03 | 38 | 51 | 2 | 33283408 | ||
| Pubmed | 1.44e-03 | 568 | 51 | 5 | 37774976 | ||
| Interaction | MEST interactions | 4.27e-06 | 45 | 49 | 4 | int:MEST | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.20e-06 | 188 | 50 | 5 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | TCGA-Brain-Recurrent_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.47e-05 | 132 | 50 | 4 | 6a6718582edfc59c63f2c8f753be81e0f4a7246b | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-05 | 172 | 50 | 4 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 4.24e-05 | 173 | 50 | 4 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.63e-05 | 177 | 50 | 4 | 37d1abe1a9d8f2b8f4d146bbf1db94104eab6593 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.05e-05 | 181 | 50 | 4 | 7e3bcfa2ba5b98a7df5854aa6e7a31e9a71faa8a | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.16e-05 | 182 | 50 | 4 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-05 | 184 | 50 | 4 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 187 | 50 | 4 | c81d11d9fdc22dc39222f62c2888025c2e8c3e65 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 5.73e-05 | 187 | 50 | 4 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.85e-05 | 188 | 50 | 4 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 6.10e-05 | 190 | 50 | 4 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.10e-05 | 190 | 50 | 4 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.10e-05 | 190 | 50 | 4 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.61e-05 | 194 | 50 | 4 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | Control-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 6.88e-05 | 196 | 50 | 4 | e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.88e-05 | 196 | 50 | 4 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.88e-05 | 196 | 50 | 4 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | normal_Lung-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 7.01e-05 | 197 | 50 | 4 | 80b3902ceea242148a1f1707c633f66afedf5183 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.15e-05 | 198 | 50 | 4 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.15e-05 | 198 | 50 | 4 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | droplet-Skin-nan-21m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 198 | 50 | 4 | db9507386cdccbde7389a77667dbd0e5550ed4df | |
| Disease | autosomal dominant polycystic kidney disease (is_marker_for) | 2.33e-04 | 14 | 48 | 2 | DOID:898 (is_marker_for) | |
| Disease | Non-steroidal anti-inflammatory and antirheumatic product use measurement | 2.68e-04 | 15 | 48 | 2 | EFO_0009935 | |
| Disease | Autism Spectrum Disorders | 3.63e-04 | 85 | 48 | 3 | C1510586 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 3.90e-04 | 18 | 48 | 2 | EFO_1000649, HP_0000131 | |
| Disease | descending aortic diameter | 4.02e-04 | 88 | 48 | 3 | EFO_0021788 | |
| Disease | JT interval | 7.09e-04 | 248 | 48 | 4 | EFO_0007885 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 8.21e-04 | 26 | 48 | 2 | DOID:234 (is_implicated_in) | |
| Disease | Autistic Disorder | 8.57e-04 | 261 | 48 | 4 | C0004352 | |
| Disease | Child Development Disorders, Specific | 1.02e-03 | 29 | 48 | 2 | C0085997 | |
| Disease | Child Development Deviations | 1.02e-03 | 29 | 48 | 2 | C0085996 | |
| Disease | Developmental Disabilities | 1.09e-03 | 30 | 48 | 2 | C0008073 | |
| Disease | right ventricular ejection fraction measurement | 1.09e-03 | 30 | 48 | 2 | EFO_0021816 | |
| Disease | Uterine leiomyoma, breast carcinoma | 1.25e-03 | 32 | 48 | 2 | EFO_0000305, HP_0000131 | |
| Disease | Sclerocystic Ovaries | 1.68e-03 | 144 | 48 | 3 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 1.68e-03 | 144 | 48 | 3 | C0032460 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.96e-03 | 152 | 48 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 3.19e-03 | 616 | 48 | 5 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.19e-03 | 616 | 48 | 5 | C0376358 | |
| Disease | basal cell carcinoma | 3.62e-03 | 189 | 48 | 3 | EFO_0004193 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 4.75e-03 | 63 | 48 | 2 | DOID:0050866 (is_marker_for) | |
| Disease | Abdominal Aortic Aneurysm | 5.51e-03 | 68 | 48 | 2 | EFO_0004214 | |
| Disease | allergic disease, age at onset | 5.99e-03 | 71 | 48 | 2 | EFO_0004847, MONDO_0005271 | |
| Disease | perceived unattractiveness to mosquitos measurement | 6.16e-03 | 72 | 48 | 2 | EFO_0008380 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LTLPKVLLKLLPGFG | 96 | P59826 | |
| LIPPLIKPGLLKAWG | 126 | Q9H0P7 | |
| LLLPGKPDKSGRPIS | 716 | Q9HCE6 | |
| LGLPKLYLPTGPRRG | 71 | P38936 | |
| EPKPLLFLPAAGAGR | 41 | Q6UXT8 | |
| GLAPLPFPGLSKLNL | 166 | Q99581 | |
| KQLLLPKRGPSTPGG | 1061 | Q68CP9 | |
| GLPLPKTPEKRGDLI | 301 | P25685 | |
| LKLRFGLLPLTGGPR | 91 | A0A5F9ZHS7 | |
| GPLLPSPARGLKFLK | 446 | Q9HCH0 | |
| PPKKRSILGLGQARP | 256 | Q4VC44 | |
| KLSFKGPRLALPGAG | 36 | Q9HAT1 | |
| RQALRLLLPGPFPGK | 141 | Q2KJY2 | |
| RQLLKPPLKKLPLGG | 1076 | A9Z1Z3 | |
| PKLSFLKPGILTGRG | 651 | O95786 | |
| KPRAKNASGRPLPLG | 151 | P55107 | |
| PLLKKPGAASPLASR | 771 | Q9UN70 | |
| ALKPLPLLRPGQAKT | 146 | Q969R2 | |
| PPRKKPGLASFRLSG | 7441 | Q5VST9 | |
| LLRKKTLVPGPPGSS | 101 | Q14318 | |
| PGALLGPKPKLKGSL | 226 | Q14549 | |
| PGAPLEKPGRREKLL | 141 | O95873 | |
| GIGFRKEKRNLPPLP | 286 | Q9ULE3 | |
| SPLKPFLKLSLGLPG | 56 | P15391 | |
| SGNKPPGLLPRKGLY | 51 | Q9Y2Q3 | |
| LRTLKAPDGLPALGP | 26 | Q5VSG8 | |
| QRPKGLGLGFPLPKS | 501 | Q9NW75 | |
| GLRNDKDKPLPPLLA | 1391 | Q14839 | |
| KDKPLPPLLARVGGN | 1396 | Q14839 | |
| KKSGLFGLPPLAPLP | 41 | Q6NUJ5 | |
| PDLPPQAKKAGRGLF | 421 | Q9ULN7 | |
| REAPAFLKLPLGSPG | 156 | Q9NY99 | |
| KPLGPARASGLSKKP | 756 | Q9UQ84 | |
| PGPKRKLYSAVPGRL | 516 | Q9UPX8 | |
| PLFGGRLTKPERGKL | 491 | P28288 | |
| LAKKAGLRGKPPPQS | 111 | Q68D42 | |
| SALAPKIGPLGLSPK | 26 | P30050 | |
| LLGLPGALLKYIGPL | 231 | Q9UGH3 | |
| PKLKSPLGKGPVTFR | 1416 | Q9BYB0 | |
| PLGKGPVTFRDPLLK | 1421 | Q9BYB0 | |
| LLGLRFLGAPAKPPL | 296 | P42226 | |
| RLLRSLVFPGGKKPG | 181 | Q3SY52 | |
| FSGKPPEKLLPNRKG | 121 | Q658T7 | |
| KLPFLKRRGGGIDPT | 266 | Q8TEQ6 | |
| GKALLPAVRTLKPPG | 266 | Q9Y6F9 | |
| SKQPPTPLLGRKFFG | 2121 | Q9H254 | |
| PKKPFLLGPQRLSSA | 211 | Q7L804 | |
| KGQKLLLFPSPPGEA | 536 | Q5SNT2 | |
| IPLVGIKGAALPKLP | 356 | Q96JH7 | |
| LLFPSRPGLLKDPGV | 516 | Q9NNW5 | |
| KEKALFLPGGALPSP | 81 | O95201 | |
| GPLSLLAPLPAAGKK | 321 | Q8NAF0 | |
| PKSPLGLFIRKPFIK | 351 | Q9UBN4 | |
| KRPKLLIFIIPGNPG | 41 | Q9H6V9 |